IN BRIEF: Midatech Pharma Terminates Formal Sales Process

Fri, 24th Jul 2020 17:24

Midatech Pharma PLC - drug delivery company - Terminates formal sales process which kicked off in April. Currently evaluating proposals from third parties, including for the potential acquisition of some company assets which would count as a reverse takeover.

Current stock price: 39.50 pence

Year-to-date change: down 29%

By Eric Cunha; ericcunha@alliancenews.com

Related Shares

More News

24 Mar 2023 18:17

IN BRIEF: Midatech Pharma delisting and name change approved

Midatech Pharma PLC - Cardiff-based R&D biotechnology company focused on improving the bio-delivery and bio-distribution of medicines - Says resolutio...

17 Mar 2023 15:42

UK shareholder meetings calendar - next 7 days

15 Feb 2023 10:35

Midatech Pharma shares up as closed USD6.0 million private placement

(Alliance News) - Midatech Pharma PLC on Wednesday said it has raised USD6.0 million through a private placement of 10.3 million shares at USD0.58 eac...

9 Feb 2023 20:25

IN BRIEF: Midatech Pharma raises USD6.0 million for clinical asset

Midatech Pharma PLC - Cardiff-based R&D biotechnology company focused on improving the bio-delivery and bio-distribution of medicines - Raises gross p...

3 Feb 2023 11:42

Midatech's Nasdaq price falls below minimum of USD1.00 per share

(Alliance News) - Midatech Pharma PLC on Friday said it received notice that its share price has fallen short of the minimum needed according to Nasda...